Publication & Citation Trends
Publications
0 total
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.
Cited by 0
Semantic Scholar
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysis
Cited by 0
Semantic Scholar
Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma.
Cited by 0
Semantic Scholar
Epigenetic evolution of IDHwt glioblastomas.
Cited by 0
Semantic Scholar
BIOM-09. PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA
Cited by 0
Semantic Scholar
INNV-04. Association of proton pump inhibitor use with outcome of patients with newly diagnosed glioblastoma
Cited by 0
Semantic Scholar
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma
Cited by 1
Semantic Scholar
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer.
Cited by 2
Semantic Scholar
Research Topics
Glioma Diagnosis and Treatment
(297)
Brain Metastases and Treatment
(105)
Radiomics and Machine Learning in Medical Imaging
(83)
Epigenetics and DNA Methylation
(50)
Cancer Genomics and Diagnostics
(39)
Affiliations
Ontario Institute for Cancer Research
European Organisation for Research and Treatment of Cancer
Sunnybrook Health Science Centre
Radboud University Nijmegen
Inserm